Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancer
Autor: | Fatemeh Fekrmandi, Tim Jaung, Alexi A. Wright, Judy Garber, Huma Q. Rana, Kristin Hehir, Ursula A. Matulonis, Angel M. Cronin, Samantha Stokes, Lindsay Kipnis, Donna Rachel Vatnick |
---|---|
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Adult medicine.medical_specialty Time Factors Genetic counseling Genetic Counseling Gynecologic oncology Medical Oncology 03 medical and health sciences Young Adult 0302 clinical medicine medicine Cancer Family Humans Genetic Predisposition to Disease Genetic Testing Prospective Studies Prospective cohort study Medical History Taking Referral and Consultation Genetic testing Aged Aged 80 and over Ovarian Neoplasms medicine.diagnostic_test business.industry Obstetrics and Gynecology Guideline Middle Aged medicine.disease 030104 developmental biology Counselors Oncology 030220 oncology & carcinogenesis Family medicine Practice Guidelines as Topic Patient Compliance Female Ovarian cancer business |
Zdroj: | Gynecologic oncology. 160(2) |
ISSN: | 1095-6859 |
Popis: | Objective Germline genetic testing is crucial to the care of ovarian cancer patients, and as part of the guideline-based care for ovarian cancer patient's adherence to this recommendation has been low. We sought to determine whether embedding a genetic counselor (GC) within a medical and gynecologic oncology clinic would increase testing rates and improve the timeliness of testing. Methods Prospective cohort study of 358 ovarian cancer patients seen by medical and gynecologic oncologists between 2013 and 2015. Rates of referrals, completion of counseling, and genetic testing and timeliness of counseling were abstracted before and after a GC was embedded in the clinic in 2014. An additional year of data (2015) was collected to evaluate sustainability of the intervention. Results Between 2013 and 2015, 88–92% of women were referred for genetic testing, but in 2013 only 66% completed counseling and 61% were tested. After a GC was embedded in the clinic in 2014, more than 80% of referred women completed counseling and germline genetic testing. Time to genetic counseling also decreased from a median of 107 to 40 days, irrespective of age and cancer family history (p Conclusions Embedding a GC into the workflow for ovarian cancer patients is an effective way of improving access to genetic counseling, testing rates, and the timeliness of testing. |
Databáze: | OpenAIRE |
Externí odkaz: |